The Lancet HIV
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
- PublisherELSEVIER INC
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year2014
- Publisher URL
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has The Lancet HIV been publishing? 
The The Lancet HIV has been publishing since 2014 till date.
How frequently is the The Lancet HIV published?
The Lancet HIV is published Monthly.
Who is the publisher of The Lancet HIV?
The publisher of The Lancet HIV is ELSEVIER INC.
How can I view the journal metrics of The Lancet HIV on editage?
For the The Lancet HIV metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of The Lancet HIV?
The eISSN number is 2352-3018 and pISSN number is 2352-3018 for The Lancet HIV.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cohort study, Viral load, Public health, Assay, Substance abuse, Randomized controlled trial, Misinformation, Opioid use, Burden of disease, Lamivudine, Placebo, Health professionals, Drug resistance, Seroconversion, Transgender, Systematic review, Interrupted time series, Median time, Observational study, Opioid use disorder.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.